Speak directly to the analyst to clarify any post sales queries you may have.
Dried blood spot collection cards are accelerating modern diagnostic workflows by enabling decentralized, efficient, and minimally invasive sample collection. Senior decision-makers increasingly see these cards as essential for scalable, patient-centric healthcare delivery and improved operational effectiveness.
Market Snapshot: Dried Blood Spot Collection Cards Market Growth
The dried blood spot collection cards market expanded from USD 384.31 million in 2024 to USD 405.41 million in 2025, reflecting strong industry momentum across clinical diagnostics and public health initiatives. With a compound annual growth rate of 5.59%, projections indicate the market will reach USD 532.83 million by 2030. Strategic growth drivers include increasing market demand for diagnostic accuracy, expanding regulatory acceptance, and the integration of these cards into digital healthcare workflows. Industry leaders are responding with proven solutions that support changing testing needs while meeting the requirements for decentralized and patient-focused diagnostics.
Scope & Segmentation: Strategic Market Analysis
This research delivers a comprehensive evaluation of the dried blood spot collection cards market, offering actionable insights for decision-makers seeking clarity in a complex and evolving sector. The study includes in-depth analysis on major product lines, technological advancements, and strategic market segments:
- Product Types: Filter paper cards and polymer coated cards, each supporting different levels of sample stability and suitability for a range of diagnostic workflows.
- Technology: Advanced DBS cards and standard DBS cards, enabling laboratories and clinics to match technology solutions to sensitivity and application requirements.
- Sample Types: Plasma spots, serum spots, and whole blood spots, meeting analytical needs for both screening and confirmatory testing protocols.
- Applications: Clinical diagnostics, disease surveillance, forensic toxicology, newborn screening (covering congenital hypothyroidism, cystic fibrosis, phenylketonuria), and therapeutic drug monitoring, ensuring broad adoption in critical health domains.
- End Users: Diagnostic laboratories, home care settings, hospitals and clinics, and research institutes, reflecting the full spectrum of healthcare delivery models.
- Distribution Channels: Direct sales and distributors/wholesalers, tailored to organizational procurement preferences in different markets.
- Geographies: Analysis spans Americas, Europe, Middle East & Africa, and Asia-Pacific, offering region- and country-level insights including key markets such as North America and Asia-Pacific.
- Company Coverage: Profiles of over 20 innovative companies, highlighting leadership in R&D, manufacturing, and strategic partnerships within the industry.
Key Takeaways: Expert Insights for Decision-Makers
- Transition to polymer-coated dried blood spot collection cards is enabling higher sensitivity in diagnostics by improving sample stability and analyte recovery in demanding clinical settings.
- Integration with digital health and telemedicine platforms is strengthening patient management and remote monitoring, supporting continuity of care and facilitating decentralized workflows.
- Regulatory authorities are broadening acceptance of dried blood spot methodologies, especially in newborn screening and infectious disease programs, which is catalyzing wider clinical uptake.
- Decentralized sampling and home-based collection are extending diagnostic reach, supporting patient-centric approaches and enhancing healthcare access across varied resource environments.
- Collaboration between technology vendors, healthcare providers, and laboratories is advancing compatibility with mass spectrometry and reinforcing process integration.
- Growth in eco-friendly packaging and adoption of recyclable materials is distinguishing market participants focused on sustainability and corporate responsibility.
Tariff Impact: Adapting to U.S. Tariff Changes
The 2025 U.S. tariff revisions have driven significant supply chain adjustments in the dried blood spot card sector. Increased duties on raw materials, such as specialty filter paper and polymers, are prompting manufacturers to revise sourcing strategies. Many organizations are moving toward regional manufacturing centers and pursuing new supplier partnerships to counteract rising costs and procurement challenges. These measures, alongside ongoing industry policy advocacy, are resulting in a more resilient and regionally diversified supply network.
Methodology & Data Sources
This analysis is built on a mixed-methods research approach, utilizing over 30 primary expert interviews, structured surveys, and extensive secondary sources—including regulatory, patent, and industry reports. Stringent data triangulation and validation by a global advisory group support the reliability of findings, while advanced quantitative methods highlight market trends and pinpoint emerging opportunities.
Why This Report Matters: Strategic Value for Senior Leaders
- Enables informed investment and procurement strategies through detailed segment analysis and technology adoption insights relevant to operational excellence.
- Guides commercial teams to opportunities in home care, digital diagnostics, and sustainable manufacturing—areas driving future growth and differentiation.
- Supports supply chain risk mitigation and agile response to changing tariff and sourcing conditions, providing clarity amid evolving market dynamics.
Conclusion
The dried blood spot collection cards market is positioned for sustained advancement, driven by innovation, regulatory progress, and digital transformation. Stakeholders leveraging these market insights can enhance resilience and capture new opportunities in diagnostics delivery.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this Dried Blood Spot Collection Cards market report include:- Ahlstrom Oyj
- ARCHIMEDlife GmbH by amedes Holding GmbH
- BioIVT LLC
- Cambrian Biotech Pvt. Ltd.
- Capitainer AB
- CENTOGENE GmbH
- Chemie-Erzeugnisse und Adsorptionstechnik AG
- Eastern Business Forms, Inc
- F. Hoffmann-La Roche Ltd.
- Huachenyang (Shenzhen) Technology Co., Ltd
- Inotiv, Inc.
- Kala Scientific INC.
- Merck KGaA
- Monobind Inc.
- QIAGEN N.V.
- RDA Spot Inc
- Salimetrics, LLC.
- Shimadzu Corporation
- Tianjin Geneally Biotechnology Co., Ltd.
- DBS System SA
- OmegaQuant Analytics, LLC
- ADVANTEC MFS, INC.
- Telimmune LLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 188 |
Published | October 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 405.41 Million |
Forecasted Market Value ( USD | $ 532.83 Million |
Compound Annual Growth Rate | 5.5% |
Regions Covered | Global |
No. of Companies Mentioned | 24 |